Perseus Proteomics: Announcements of individual stocks: The mid-term report for the clinical trial of PPMX-T003 has been adopted at the 14th JSH International Symposium in 2024.

JPX · Jun 17 15:05

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.